AzTrials
AzTrials

Open Fracture WoundsFLOWNCT00788398

Fluid Lavage of Open Wounds

A study testing Saline Solution, Soap solution and Gravity Flow Irrigation in people with Open Fracture Wounds, run by Prisma Health-Upstate at 31 sites in 5 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Open fracture wounds are a constant challenge to orthopaedic surgeons, with infections a common complication. There is currently little evidence as to which is the most effective way to wash out these wounds. This study is a multi-center, prospective, randomized study. Read more about this study

Who is it for?
Ages 14 to 85 years
Conditions the study is for
Open Fracture Wounds
What is being tested?
Saline Solution, Soap solution and Gravity Flow Irrigation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,540 participants
Where
31 sitesin 5 countries
Study dates
Jun 2009to Apr 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 85 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Men or women who are skeletally mature.
  • Fracture of any extremity with complete radiographs.
  • Open fractures (Gustilo-Anderson Types I-IIIB) (Table 2)*.
  • Fracture requiring operative fixation.
  • Provision of informed consent.

Who cannot join

  • Open fractures with an associated vascular deficit (Gustilo-Anderson Type IIIC).
  • Known allergy to detergents or castile soap ingredients.
  • Previous wound infection or history of osteomyelitis in the injured extremity.
  • Previous fracture with retained hardware in injured extremity that will interfere with new implant fixation.
  • Surgical delay to operative wound management greater than 24 hours from hospital admission.
  • Use of immunosuppressive medication within 6 months.
Show all 11Show fewer
  • Immunological deficient disease conditions (e.g. HIV).
  • Fracture of the hand (metacarpals and phalanges).
  • Fracture of the toes (phalanges).
  • Likely problems, in the judgment of the investigators, with maintaining follow-up. We will, for example, exclude patients with no fixed address, those who report a plan to move out of town in the next year, or intellectually challenged patients without adequate family support.
  • Previous randomization in this study or a competing study.

Trial locations and contacts

31 sites in 5 countries.

31 sites in 5 countries

United States14 sites
  • Univeristy of Alabama at Birmingham

    Birmingham, Alabama, 35294

  • Lahey Clinic

    Burlington, Massachusetts, 01805

  • University of Missouri Health Care

    Columbia, Missouri, 65212

  • Miami Valley Hospital/Wright State University

    Dayton, Ohio, 45409

  • Duke University

    Durham, North Carolina, 27710

  • Brooke Army Medical Center

    Fort Sam Houston, Texas, 78234

  • Orthopaedic Associates of Michigan

    Grand Rapids, Michigan, 49503

  • Greenville Hospital System

    Greenville, South Carolina, 29605

  • Wishard Health Services, Indiana University

    Indianapolis, Indiana, 46202

  • Hennepin County Medical Center

    Minneapolis, Minnesota, 55415

  • University of California-Irvine

    Orange, California, 92868

  • University of Pittsburg

    Pittsburgh, Pennsylvania

  • University of California- San Francisco

    San Francisco, California, 94110

  • St. Louis University

    St Louis, Missouri, 63110

Other trials in United States

Canada14 sites
  • Queen Elizabeth II Health Sciences Center

    Halifax, Nova Scotia, B3H 3A7

  • Hamilton Health Sciences

    Hamilton, Ontario, L8L 2X2

  • McMaster University

    Hamilton, Ontario

  • London Health Sciences

    London, Ontario

  • McGill University Health Centre

    Montreal, Quebec, H3G-1A4

  • Hospital du Sacre-Coeur de Montreal

    Montreal, Quebec, H4J 1C5

  • Royal Columbian Hospital-New Wesminster

    New Westminster, British Columbia, V3L 5P5

  • Ottawa Hospital- Civic

    Ottawa, Ontario, K1V 4E9

  • Hôpital de l'Enfant-Jésus

    Québec, Quebec

  • Université de Sherbrooke

    Sherbrooke, Quebec

  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, M4N 3M5

  • St. Michael's Hospital

    Toronto, Ontario, M5C 1R6

  • Vancouver General Hospital

    Vancouver, British Columbia, V5Z 1M9

  • Health Sciences Winnipeg

    Winnipeg, Manitoba, R3A 1R9

Other trials in Canada

Australia1 site
  • The Alfred

    Prahran, VIC 3181

Other trials in Australia

India1 site
  • Sancheti Institute

    Prune

Other trials in India

Norway1 site
  • Ulleval University Hospital

    Oslo

Other trials in Norway

About this study

Official title: Fluid Lavage of Open Wounds (FLOW): A Multi-center, Blinded, Factorial Trial Comparing Alternative Irrigating Solutions and Pressures in Patients With Open Fractures

Open fracture wounds are a constant challenge to orthopaedic surgeons, with infections a common complication. There is currently little evidence as to which is the most effective way to wash out these wounds. This study is a multi-center, prospective, randomized study. The infection rates will be compared between irrigation using high pressure versus low pressure versus gravity flow, and also saline versus a soap solution as the irrigation solution. The results from this study will help to determine the best method of washing out open fractures wounds. In this study, all open wounds will be washed out using methods commonly used by orthopaedic surgeons

Being tested
Saline Solution, Soap solution, Gravity Flow Irrigation, Low Pressure Irrigation, High Pressure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Saline SolutionProcedure or surgery

    Irrigation with Saline

  • Soap solutionProcedure or surgery

    Irrigation with Castile Soap Solution (80 ml per 3L bag of saline)

  • Gravity Flow IrrigationProcedure or surgery

    Gravity flow irrigation will be standardized across participating centers as 3L bags of normal saline (alone or with soap solution) suspended 6-8 feet above floor level using an I.V. pole. Irrigation tubing (measuring 1/4 - 3/8 inch inner diameter) will be connected to the 3L bag and secured with a stopcock (or compressive device) until ready for use.

  • Low Pressure IrrigationProcedure or surgery

    Irrigation with the Stryker SurgiLav System. At the low pressure setting delivers 5.9 p.s.i. pressure. The high-flow irrigator tip will be held perpendicular to and 5cm above the wound.

    Irrigation with the Zimmer PulsaVac. For low pressure delivery, the shower tip will be used at the low pressure setting which delivers a pressure of 5.8 p.s.i.

  • High PressureProcedure or surgery

    Irrigation with the Stryker SurgiLav System. For the high pressure delivery, the multi-orifice tip will be used at the high setting which delivers a pressure of 30 p.s.i.

    Irrigation with the Zimmer PulsaVac System: For the high pressure delivery the shower tip will be used at the high pressure setting which delivers a pressure of 23 p.s.i.

Study groups in NCT00788398
Study groupRoleWhat they receive
Saline, gravity flowActive comparatorNot described
Receives: Procedure: Saline Solution; Procedure: Gravity Flow Irrigation
Saline, Low PressureActive comparatorNot described
Receives: Procedure: Saline Solution; Procedure: Low Pressure Irrigation
Saline, High PressureActive comparatorNot described
Receives: Procedure: Saline Solution; Procedure: High Pressure
Soap, Gravity FlowActive comparatorNot described
Receives: Procedure: Soap solution; Procedure: Gravity Flow Irrigation
Soap, low pressureActive comparatorNot described
Receives: Procedure: Soap solution; Procedure: Low Pressure Irrigation
Soap, high pressureActive comparatorNot described
Receives: Procedure: Soap solution; Procedure: High Pressure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Re-operation within 12 months post initial surgery to treat an infection, manage a wound healing problem, or promote fracture healing.

    Measured: within 12 months

Secondary outcomes (1)
  1. Patient function and quality of life measured by the Short Form-12 (SF-12) and the EuroQol-5D

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Nov 2008 (estimated)
  2. Study startJun 2009
  3. Primary completionJan 2015
  4. Study completionApr 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
2,540 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00788398
Sponsor's protocol ID
GHS-03-08-06
Other IDs
W81XWH-08-1-0473
Acronym
FLOW
Status last verified
Feb 2016
First submitted
7 Nov 2008
Last updated
11 Feb 2016
Results posted
No
Data monitoring committee
Yes

Publications

  • Tornetta P 3rd, Della Rocca GJ, Morshed S, Jones C, Heels-Ansdell D, Sprague S, Petrisor B, Jeray KJ, Del Fabbro G, Bzovsky S, Bhandari M; FLOW Investigators. Risk Factors Associated With Infection in Open Fractures of the Upper and Lower Extremities. J Am Acad Orthop Surg Glob Res Rev. 2020 Dec 8;4(12):e20.00188. doi: 10.5435/JAAOSGlobal-D-20-00188.

    PubMed 33986214
  • Prada C, Marcano-Fernandez FA, Schemitsch EH, Bzovsky S, Jeray K, Petrisor B, Bhandari M, Sprague S; FLOW Investigators. Timing and Management of Surgical Site Infections in Patients With Open Fracture Wounds: A Fluid Lavage of Open Wounds Cohort Secondary Analysis. J Orthop Trauma. 2021 Mar 1;35(3):128-135. doi: 10.1097/BOT.0000000000001912.

    PubMed 33105456
  • Busse JW, Heels-Ansdell D, Makosso-Kallyth S, Petrisor B, Jeray K, Tufescu T, Laflamme Y, McKay P, McCabe RE, Le Manach Y, Bhandari M; Fluid Lavage of Open Wounds Investigators. Patient coping and expectations predict recovery after major orthopaedic trauma. Br J Anaesth. 2019 Jan;122(1):51-59. doi: 10.1016/j.bja.2018.06.021. Epub 2018 Aug 6.

    PubMed 30579406
  • Sprague S, Tornetta P 3rd, Slobogean GP, O'Hara NN, McKay P, Petrisor B, Jeray KJ, Schemitsch EH, Sanders D, Bhandari M; FLOW Investigators. Are large clinical trials in orthopaedic trauma justified? BMC Musculoskelet Disord. 2018 Apr 20;19(1):124. doi: 10.1186/s12891-018-2029-3.

    PubMed 29678204
  • Shea P, O'Hara NN, Sprague SA, Bhandari M, Petrisor BA, Jeray KJ, Zhan M, Slobogean GP, Pensy RA; Fluid Lavage in Open Wounds Investigators. Wound Surface Area as a Risk Factor for Flap Complications among Patients with Open Fractures. Plast Reconstr Surg. 2018 Jul;142(1):228-236. doi: 10.1097/PRS.0000000000004418.

    PubMed 29608532
  • FLOW Investigators; Bhandari M, Jeray KJ, Petrisor BA, Devereaux PJ, Heels-Ansdell D, Schemitsch EH, Anglen J, Della Rocca GJ, Jones C, Kreder H, Liew S, McKay P, Papp S, Sancheti P, Sprague S, Stone TB, Sun X, Tanner SL, Tornetta P 3rd, Tufescu T, Walter S, Guyatt GH. A Trial of Wound Irrigation in the Initial Management of Open Fracture Wounds. N Engl J Med. 2015 Dec 31;373(27):2629-41. doi: 10.1056/NEJMoa1508502. Epub 2015 Oct 8.

    PubMed 26448371
  • Flow Investigators. Fluid lavage of open wounds (FLOW): design and rationale for a large, multicenter collaborative 2 x 3 factorial trial of irrigating pressures and solutions in patients with open fractures. BMC Musculoskelet Disord. 2010 May 6;11:85. doi: 10.1186/1471-2474-11-85.

    PubMed 20459600

Questions about this trial

What is this clinical trial studying?

A study testing Saline Solution, Soap solution and Gravity Flow Irrigation in people with Open Fracture Wounds, run by Prisma Health-Upstate at 31 sites in 5 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Feb 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 31 sites in United States, Canada, Australia, India, Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Re-operation within 12 months post initial surgery to treat an infection, manage a wound healing problem, or promote fracture healing. (time frame: within 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00788398, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Feb 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in